Treatment for Fungal Skin Infections
For most superficial fungal skin infections, topical antifungal agents are the first-line treatment, with systemic therapy reserved for extensive disease, nail infections, scalp infections, or treatment failures. 1
Treatment by Infection Type
Candidal Skin Infections (Intertrigo)
- Topical azoles (clotrimazole, miconazole) or polyenes (nystatin) are effective first-line treatments for candidal skin infections, particularly in skin folds of obese and diabetic patients 2, 1
- Keeping the infected area dry is essential for treatment success—failure to do this is a common pitfall that undermines therapy 2, 1
- Treatment duration typically ranges from 1-2 weeks with topical agents 3
Candidal Paronychia
Dermatophyte Infections (Tinea Corporis, Tinea Cruris, Tinea Pedis)
Topical therapy:
- Fungicidal agents (allylamines: terbinafine, naftifine, butenafine) are preferred over fungistatic agents (azoles) because they kill fungi rather than just inhibiting growth 3
- Allylamines achieve high cure rates with treatment as short as once daily for 1 week 3
- This is clinically important because patients often stop treatment when skin appears healed (typically after 1 week)—fungi recur more frequently with fungistatic drugs if treatment is stopped early 3
- Azoles (miconazole, clotrimazole, ketoconazole) remain effective alternatives, particularly for mixed infections or yeast involvement 3, 4
Systemic therapy (for extensive or resistant cases):
- Terbinafine 250 mg daily for 1-2 weeks 5
- Itraconazole 100 mg daily for 2 weeks or 200 mg daily for 7 days 5
- Fluconazole 50-100 mg daily or 150 mg once weekly for 2-3 weeks 5
Tinea Capitis (Scalp Ringworm)
- Oral therapy is required—topical agents alone are ineffective 2, 1
- Griseofulvin remains the only licensed treatment for children in the UK: 20 mg/kg daily for 6-8 weeks, taken with fatty food to improve absorption 2
- Treatment should ideally await fungal confirmation, but in high-risk populations with typical features (scaling, lymphadenopathy, alopecia) or kerion, start therapy immediately 2
- Add topical antifungal shampoos (ketoconazole 2%, selenium sulfide 1%, or povidone-iodine) to reduce spore transmission, though these alone are insufficient for cure 2
Onychomycosis (Nail Infections)
- Topical agents are ineffective for nail infections—oral therapy is required 1
- For dermatophyte nail infections: terbinafine or itraconazole are preferred over griseofulvin 1
- For Candida onychomycosis: azoles are preferred because terbinafine has limited activity against yeasts 1
- Treatment duration is prolonged (typically 6-12 weeks or longer) due to slow nail growth 4
Pityriasis Versicolor
Topical therapy (first-line):
- Topical azoles or selenium sulfide for localized disease 4
Systemic therapy (for extensive disease):
- Itraconazole 200 mg daily for 5-7 days 5, 4
- Fluconazole 400 mg as a single dose 5, 4
- Note: Terbinafine is ineffective for pityriasis versicolor 5
Critical Pitfalls to Avoid
- Do not use topical therapy alone for tinea capitis or onychomycosis—these require systemic treatment 2, 1
- Do not prescribe terbinafine for yeast infections (Candida or pityriasis versicolor)—it lacks adequate activity against yeasts 1, 5
- Ensure the infected area stays dry, especially for intertrigo—moisture undermines treatment efficacy 2, 1
- Be aware of emerging terbinafine resistance in Trichophyton mentagrophytes ITS genotype VIII (T. indotineae)—if treatment fails, consider resistance testing and switch to itraconazole 4
- Patients often stop treatment when skin appears healed (typically after 1 week)—this is why fungicidal agents (allylamines) are preferred over fungistatic agents (azoles) for dermatophyte infections 3
Special Considerations
- For widespread infections, hair follicle involvement, or treatment failures, systemic therapy is necessary 3
- Cost considerations may influence choice, especially for large body surface areas—generic topical agents are generally effective regardless of mechanism 3
- Always combine oral antifungal treatment with topical therapy for optimal outcomes 4